While current clinical trials for cardiac regeneration using induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) employ immunosuppressive regimens used in heart transplants, the precise ...
Cardiovascular disease continues to lead as the primary cause of death across the globe, taking millions of lives every year. Damage caused by these diseases is particularly difficult to repair, since ...
TOKYO & PALO ALTO, Calif.--(BUSINESS WIRE)--Heartseed Inc. ("Heartseed"), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure and I Peace Inc. ("I Peace"), a ...
New evidence reveals adult human hearts can regrow muscle cells after myocardial infarction, opening new possibilities for ...
In a recent study published in Science Advances, researchers generated a recombinant influenza virus expressing micro ribonucleic acid (miRNAs) expressed in cardiomyocytes to infect mice, which served ...
Novel technology returns cardiomyocytes to a stem cell-like state to promote their proliferation and regeneration in an in vitro study. Researchers at the University of Houston (TX, USA) have ...
The induction of the cell cycle in cardiomyocytes involves the activation of specific genes that are responsible for regulating cell division and growth. Our laboratory has discovered several ...
Researchers reveal that cardiomyocytes and skeletal muscle cells replace their existing stock of ribosomes with a different type which can make physical contact with mitochondria, the batteries of the ...
Novel tissue-embedded nanosensor shows that co-culturing stem-cell-derived cardiomyocytes with endothelial cells leads to more functionally mature cardiomyocytes. Heart muscle cells, called ...
Growing new cells is the holy grail for cardiologists. But this rare heart, frozen in time for 18 years in Sydney, held the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results